• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西南部社区女性尿液样本中产大肠埃希菌尿路感染患者对一线抗菌治疗药物的敏感性。

Susceptibility to first choice antimicrobial treatment for urinary tract infections to Escherichia coli isolates from women urine samples in community South Brazil.

机构信息

Universidade Estadual de Londrina, Departamento de Medicina Interna, Londrina, PR, Brazil.

Universidade Estadual de Londrina, Departamento de Microbiologia, Londrina, PR, Brazil.

出版信息

Braz J Infect Dis. 2022 May-Jun;26(3):102366. doi: 10.1016/j.bjid.2022.102366. Epub 2022 May 18.

DOI:10.1016/j.bjid.2022.102366
PMID:35594950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9217753/
Abstract

UNLABELLED

E. coli is the main pathogen of UTI. It is important to be aware the local epidemiological data for an appropriate initial treatment. Resistance to antimicrobial agents has increased, especially to first-choice antibiotics in the treatment of cystitis. There are few studies on the sensivity profile of community uropathogen in our region.

OBJECTIVE

To characterize antimicrobials the sensitivity profile to E. coli isolated from urocultures of women treated at Basic Health Units and Emergency Care Units of Londrina- Paraná- Brazil during a period of 12 months (June 1, 2016 to June 1, 2017).

METHODOLOGY

A cross-sectional study was carried out from June 2016 to June 2017. All urine samples collected in the Basic Health Units and Emergency Departments in the city of Londrina (Paraná State, Brazil) were sent to a Central Laboratory where the identification and antimicrobial susceptibility testing were performed. Clinical Laboratory Standards Institute (CLSI) breakpoints were used for the interpretation of susceptibility testing results.

RESULTS

56,555 urine cultures were performed in the period, of which 8,832 were positive, of which 5,377 were women. Of these samples, 4.7% were enterobacteria producing extended-spectrum beta-lactamases (ESBL) and 15.5% resistant to quinolones. TMP- SMX was resistant in more than 30% of the samples in all age groups. Among quinolone-resistant isolates, resistance to cephalothin, ampicillin and sulfamethoxazole-trimethoprim was greater than 60%. Nitrofurantoin was the only antimicrobial that showed 90% of sensitivity.

CONCLUSION

The antimicrobials sensitivity profile was similar to that reported in the literature, with TMP- SMX resistance greater than 30% in the studied samples. Nitrofurantoin maintains high sensitivity rates greater than 90%. Resistance to quinolones increases proportionally with age, as well ESBL.

摘要

目的

描述巴西隆德里纳市基本医疗单位和急诊室就诊的女性患者中段尿培养分离的大肠埃希菌对抗菌药物的敏感性特征。

方法

本研究为横断面研究,时间为 2016 年 6 月 1 日至 2017 年 6 月 1 日。从城市的基本医疗单位和急诊室采集的所有尿液样本都被送到一个中央实验室进行鉴定和药敏试验。药敏试验结果采用临床实验室标准化协会(CLSI)的折点进行解读。

结果

在研究期间共进行了 56555 次尿培养,其中 8832 次为阳性,其中 5377 次为女性。这些样本中,4.7%为产超广谱β-内酰胺酶(ESBL)的肠杆菌,15.5%对喹诺酮类药物耐药。在所有年龄段的样本中,TMP-SMX 的耐药率都超过 30%。在喹诺酮类耐药的分离株中,对头孢噻肟、氨苄西林和磺胺甲噁唑-甲氧苄啶的耐药率大于 60%。只有呋喃妥因的敏感性达到 90%。

结论

本研究中抗菌药物的敏感性特征与文献报道相似,在所研究的样本中,TMP-SMX 的耐药率大于 30%。呋喃妥因的敏感性率仍保持在 90%以上。随着年龄的增长,喹诺酮类药物的耐药性呈比例增加,同时 ESBL 的耐药性也增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bc6/9387477/f16f6bf38f06/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bc6/9387477/73a932bfa0c4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bc6/9387477/f16f6bf38f06/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bc6/9387477/73a932bfa0c4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bc6/9387477/f16f6bf38f06/gr2.jpg

相似文献

1
Susceptibility to first choice antimicrobial treatment for urinary tract infections to Escherichia coli isolates from women urine samples in community South Brazil.巴西南部社区女性尿液样本中产大肠埃希菌尿路感染患者对一线抗菌治疗药物的敏感性。
Braz J Infect Dis. 2022 May-Jun;26(3):102366. doi: 10.1016/j.bjid.2022.102366. Epub 2022 May 18.
2
Community-Acquired Uropathogenic , Antimicrobial Susceptibility, and Extended-Spectrum Beta-Lactamase Detection.社区获得性尿路致病性、抗菌药物敏感性和超广谱β-内酰胺酶检测。
MEDICC Rev. 2022 May 16;24(2):20-25. doi: 10.37757/mr2022.v24.n2.2.
3
Prevalence and risk factors for trimethoprim-sulfamethoxazole-resistant Escherichia coli among women with acute uncomplicated urinary tract infection in a developing country.发展中国家急性单纯性尿路感染女性中耐甲氧苄啶-磺胺甲恶唑大肠杆菌的患病率及危险因素
Int J Infect Dis. 2015 May;34:55-60. doi: 10.1016/j.ijid.2015.02.022. Epub 2015 Mar 4.
4
Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.质粒介导产AmpCβ-内酰胺酶的大肠杆菌在奥克兰社区引起尿路感染,可能对常用抗菌药物耐药。
N Z Med J. 2015 Mar 13;128(1410):50-9.
5
Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.医疗保健相关尿路感染中产超广谱β-内酰胺酶大肠埃希菌和肺炎克雷伯菌的抗菌药敏性:聚焦对磷霉素的敏感性
Int Urol Nephrol. 2015 Jul;47(7):1059-66. doi: 10.1007/s11255-015-1018-9. Epub 2015 May 31.
6
[Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations].[根据美国临床和实验室标准协会(CLSI)及欧洲抗菌药物敏感性试验委员会(EUCAST)建议,产超广谱β-内酰胺酶的尿源大肠埃希菌分离株对磷霉素的敏感性]
Mikrobiyol Bul. 2014 Oct;48(4):545-55.
7
Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities.产超广谱β-内酰胺酶大肠埃希菌引起的社区获得性医疗保健相关和医院获得性尿路感染的比较及抗菌活性
Int J Clin Pract. 2015 Jul;69(7):766-70. doi: 10.1111/ijcp.12608. Epub 2015 Feb 16.
8
High prevalence of plasmid-mediated quinolone resistance in escherichia coli strains producing extended-spectrum beta-lactamases isolated from faeces and urine of pregnant women with acute cystitis.产超广谱β-内酰胺酶大肠埃希菌在急性膀胱炎孕妇粪便和尿液中的流行情况及耐药性分析。
Mol Biol Rep. 2024 Apr 24;51(1):566. doi: 10.1007/s11033-024-09491-9.
9
[Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase producing urinary isolates of Escherichia coli in outpatients].门诊患者中产超广谱β-内酰胺酶大肠埃希菌尿液分离株的流行情况及药敏分析
Srp Arh Celok Lek. 2013 Nov-Dec;141(11-12):775-9. doi: 10.2298/sarh1312775m.
10
High resistance prevalence towards ampicillin, co-trimoxazole and ciprofloxacin, among uropathogenic Escherichia coli isolates in Mexico City.墨西哥城尿路致病性大肠杆菌分离株对氨苄西林、复方新诺明和环丙沙星的高耐药率。
J Infect Dev Ctries. 2008 Oct 1;2(5):350-3. doi: 10.3855/jidc.195.

引用本文的文献

1
Antibiotic Resistance and Molecular Epidemiology of ESBL-Producing E. coli in Shrimp Aquaculture: A Study from Tiruvallur District, Tamil Nadu, India.印度泰米尔纳德邦蒂鲁瓦勒尔区对虾养殖中产超广谱β-内酰胺酶大肠杆菌的抗生素耐药性及分子流行病学研究
Curr Microbiol. 2025 Jul 22;82(9):401. doi: 10.1007/s00284-025-04329-4.
2
Emergency and persistence of Escherichia coli ST131 as community-onset antimicrobial resistant urinary tract infection in Rio de Janeiro, Brazil.巴西里约热内卢社区获得性耐抗菌药物性尿路感染中大肠杆菌ST131的出现及持续性
Braz J Infect Dis. 2025 Jul-Aug;29(4):104555. doi: 10.1016/j.bjid.2025.104555. Epub 2025 Jun 14.
3

本文引用的文献

1
Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning.美国食品药品监督管理局发布警示通告前后的门诊氟喹诺酮类药物处方模式。
Pharmacoepidemiol Drug Saf. 2020 Jun;29(6):701-707. doi: 10.1002/pds.5018. Epub 2020 May 11.
2
Susceptibility pattern of oral antimicrobials in uncomplicated UTI: Does fosfomycin still stand effective?单纯性尿路感染中口服抗菌药物的敏感性模式:磷霉素是否仍然有效?
J Family Med Prim Care. 2020 Feb 28;9(2):850-853. doi: 10.4103/jfmpc.jfmpc_970_19. eCollection 2020 Feb.
3
Treatment of Cystitis by Hungarian General Practitioners: A Prospective Observational Study.
Dominance of sequence types ST73, ST95, ST127 and ST131 in Australian urine isolates: a genomic analysis of antimicrobial resistance and virulence linked to F plasmids.
澳大利亚尿分离株中 ST73、ST95、ST127 和 ST131 序列型的优势:与 F 质粒相关的抗生素耐药性和毒力的基因组分析。
Microb Genom. 2023 Jul;9(7). doi: 10.1099/mgen.0.001068.
匈牙利全科医生对膀胱炎的治疗:一项前瞻性观察研究。
Front Pharmacol. 2019 Dec 19;10:1498. doi: 10.3389/fphar.2019.01498. eCollection 2019.
4
Antibiotic Resistance Among Uropathogenic .尿路致病性. 的抗生素耐药性
Pol J Microbiol. 2019 Dec;68(4):403-415. doi: 10.33073/pjm-2019-048. Epub 2019 Dec 5.
5
Evaluation and Management of Urinary Tract Infection in the Emergency Department.急诊科尿路感染的评估与管理
Emerg Med Clin North Am. 2019 Nov;37(4):707-723. doi: 10.1016/j.emc.2019.07.007. Epub 2019 Aug 19.
6
Evaluation of FDA Boxed Warning on Prescribing Patterns of Fluoroquinolones for Uncomplicated Urinary Tract Infections.评估 FDA 黑框警告对氟喹诺酮类药物治疗单纯性尿路感染处方模式的影响。
Ann Pharmacother. 2019 Dec;53(12):1192-1199. doi: 10.1177/1060028019865224. Epub 2019 Jul 18.
7
Changing antibiotic susceptibility pattern in uropathogenic over a period of 5 years in a tertiary care center.在一家三级医疗中心,5年期间尿路致病性细菌的抗生素敏感性模式变化情况。
Infect Drug Resist. 2019 May 29;12:1439-1443. doi: 10.2147/IDR.S201849. eCollection 2019.
8
Epidemiology of pathogens causing urinary tract infections in an urban community in southern Brazil.巴西南部一个城市社区引起尿路感染的病原体流行病学
Braz J Infect Dis. 2018 Nov-Dec;22(6):505-507. doi: 10.1016/j.bjid.2018.10.279. Epub 2018 Dec 5.
9
Community-Acquired Urinary Tract Infection by in the Era of Antibiotic Resistance.社区获得性耐药淋病奈瑟菌尿路感染。
Biomed Res Int. 2018 Sep 26;2018:7656752. doi: 10.1155/2018/7656752. eCollection 2018.
10
Incidence of multidrug resistance and extended-spectrum beta-lactamase expression in community-acquired urinary tract infection among different age groups of patients.不同年龄组患者社区获得性尿路感染中多重耐药性和超广谱β-内酰胺酶表达的发生率。
Indian J Pharmacol. 2018 Mar-Apr;50(2):69-74. doi: 10.4103/ijp.IJP_200_17.